Major RAS
the mean USS of the 8 subjects in this group was 40.6 ± 4.1 (range 35–68). After 3 months therapy the mean USS improved by 34.8% (p < 0.02). Further improvement in this group was found after 3 months, suggesting that 3 months therapy might be the minimal period to assess the efficacy of treatments (Table 